Advertisement
U.S. markets close in 5 hours 28 minutes
  • S&P 500

    5,250.32
    +1.83 (+0.03%)
     
  • Dow 30

    39,733.06
    -27.02 (-0.07%)
     
  • Nasdaq

    16,387.46
    -12.06 (-0.07%)
     
  • Russell 2000

    2,121.26
    +6.91 (+0.33%)
     
  • Crude Oil

    82.33
    +0.98 (+1.20%)
     
  • Gold

    2,226.30
    +13.60 (+0.61%)
     
  • Silver

    24.76
    +0.01 (+0.05%)
     
  • EUR/USD

    1.0811
    -0.0019 (-0.17%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • dólar/libra

    1.2642
    +0.0004 (+0.03%)
     
  • USD/JPY

    151.2740
    +0.0280 (+0.02%)
     
  • Bitcoin USD

    71,040.70
    +1,342.23 (+1.93%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,963.28
    +31.30 (+0.39%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Endo International Plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 18, 2020 - ENDP

New York, New York--(Newsfile Corp. - June 22, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Endo International Plc ("Endo") (NASDAQ: ENDP) between August 8, 2017 and June 10, 2020. You are hereby notified that a securities class action lawsuit has been commenced in the the United States District Court for the District of New Jersey. To get more information go to:

https://www.zlk.com/pslra-1/endo-international-plc-loss-submission-form?prid=7460&wire=5

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Endo's and/or its subsidiaries' contributions to the opioid crisis (including, but not limited to, their opioid products' disproportionately negative impact on New York and the fraud that Defendants perpetrated on the New York insurance market) were larger in scope than the Company had represented; (ii) part of that contribution to the crisis included Endo publishing and disseminating false information to health care providers regarding the risks and benefits of opioids; (iii) the foregoing, once revealed, was foreseeably likely to subject Endo and/or its subsidiaries to increased regulatory scrutiny and enforcement, as well as significant financial and/or reputational harm, particularly with respect to New York; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

If you suffered a loss in Endo you have until August 18, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/58326

Advertisement